Keranetics, LLC — Department of Defense SBIR Phase I: A principal approach in regenerative medicine is to stimulate or augment endogenous repair
Keranetics, LLC — SBIR Phase I award from Department of Defense.
- Amount
- $149,845
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- SBIR · Phase I
- Solicitation
- 2010.3
- NAICS
- —
- Place of performance
- NC
- Period
- 2011-02-18
Description
A principal approach in regenerative medicine is to stimulate or augment endogenous repair mechanisms that promote functional restoration of damaged or diseased tissues. When loss of significant volumes of multiple functionally integrated tissues occurs,